Global Colorectal Cancer Drugs Market 2015-2019

1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Global Colorectal Cancer Drugs Market 2015-2019
Growth, Global Share, Industry Overview,
Analysis, Trends Opportunities and Forecast
2
Description
Report Overview
About Colorectal Cancer  Colorectal cancer
refers to malignancies that originate in the
rectum or the colon. It is also known as bowel
cancer. Formation of adenocarcinomas is the most
common feature of colorectal cancer. The cancer
starts as a polyp in the inner wall of the colon
or rectum. These polyps can be benign or
malignant. Colorectal cancer is the third most
common cancer in the US. Some of the risk factors
that can cause colorectal cancer are lifestyle
changes, old age, genetic disorders, family
history, and inflammatory bowel disease. Some of
the symptoms of colorectal cancer are blood in
stool, decrease in appetite, constipation, weight
loss, nausea, bloating, and pelvic pain.
Colorectal cancer can be classified into four
broad stages. Colorectal cancer can be treated
using surgical, chemotherapeutic, biologic, and
radiation therapies.   The global colorectal
cancer drugs market to grow at a CAGR of 3.62
over the period 2014-2019.   Read more details
at http//www.bigmarketresearch.com/global-colore
ctal-cancer-drugs-2015-2019-market
3
Key Benefits
Summery
Covered in this Report  Global Colorectal Cancer
Drugs, report covers the present scenario and the
growth prospects of the global colorectal cancer
drugs market for the period 2015-2019. To
calculate the market size, the report considers
revenue generated from sales of various drugs
used in the treatment of colorectal cancer.
  Based on the type of molecule, the market is
grouped into two categories Biologics Small
molecules  Based on the route of administration,
the market is grouped into two categories
Oral Parenteral Global Colorectal Cancer
Drugs, report also presents the vendor landscape
and a corresponding detailed analysis of the top
vendors as well as the competitive performances
of their product portfolios in the market. In
addition, it discusses the major drivers that
influence the growth of the market.
4
Key Audiences
Key Regions Americas APAC EMEA   Key
Vendors Amgen Bayer Bristol-Myers Squibb
F. Hoffmann-La Roche Merck Serono  
5
Table Of Contents
Key Audiences
Other Prominent Vendors Accord Healthcare
Advenchen Laboratories Aeterna Zentaris
AstraZeneca Bavarian Nordic Biothera
Boehringer Ingelheim Daiichi Sankyo
Debiopharm Eisai Eli Lilly Immodulon
Therapeutics Mologen Mylan Nektar
Therapeutics Oncothyreon
6
Table Of Contents
Market Trends
 Market Driver Increase in population of
patients For a full, detailed list, view our
report   Market Challenge Loss of patent
exclusivity For a full, detailed list, view our
report   Market Trend Dominance of biologics
For a full, detailed list, view our
report Enquire About Report http//www.bigmarket
research.com/report-enquiry/250645
7
Get Full Information At http//www.bigmarketrese
arch.com/global-colorectal-cancer-drugs-2015-2019-
market